29550
环己基氨基磺酸
≥98.0% (T)
别名:
环己氨磺酸, 环拉酸
登录 查看组织和合同定价。
选择尺寸
变更视图
关于此项目
经验公式（希尔记法）:
C6H13NO3S
化学文摘社编号:
分子量:
179.24
UNSPSC Code:
12352100
NACRES:
NA.22
PubChem Substance ID:
EC Number:
202-898-1
Beilstein/REAXYS Number:
2208885
MDL number:
Assay:
≥98.0% (T)
Form:
solid
Quality Level
assay
≥98.0% (T)
form
solid
mp
~180 °C (dec.)
solubility
dioxane: 1 g/10 mL, clear, colorless (hot)
SMILES string
OS(=O)(=O)NC1CCCCC1
InChI
1S/C6H13NO3S/c8-11(9,10)7-6-4-2-1-3-5-6/h6-7H,1-5H2,(H,8,9,10)
InChI key
HCAJEUSONLESMK-UHFFFAOYSA-N
General description
The N-cyclohexylsulfamic acid salts of well−known therapeutic agents were prepared.
存储类别
11 - Combustible Solids
wgk
WGK 2
flash_point_f
Not applicable
flash_point_c
Not applicable
ppe
Eyeshields, Gloves, type N95 (US)
Modification of physical properties of certain antitussive and antihistaminic agents by formation of N-cyclohexylsulfamate salts.
J A CAMPBELL et al.
Journal of pharmaceutical sciences, 51, 931-934 (1962-10-01)
Lin Yi et al.
Analytical and bioanalytical chemistry, 386(3), 666-674 (2006-05-26)
Characterizing the biological effects of metabolic transformations (or biotransformation) is one of the key steps in developing safe and effective pharmaceuticals. Sulfate conjugation, one of the major phase II biotransformations, is the focus of this study. While this biotransformation typically
全球贸易项目编号
| 货号 | GTIN |
|---|---|
| 29550-500G | 04061838348555 |